发明名称 STENTS WITH COATING CONTAINING N-{5-[4-(4-METHYLPIPERAZINOMETHYL)BENZOYL-AMIDO]-2-METHYLPHENYL}-4-(3-PYRIDYL)-2-PYRIMIDINAMIN
摘要 FIELD: medicine. ^ SUBSTANCE: offered is medical device adapted for local application or introduction in hollow tubes and containing therapeutic dose of N-{5-[4-(4-methylpiperazinomethyl) benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidinamine or its salt, crystal form with possible release thereof, its application for prevention or reduction of dysfunction caused by approach to vessels and related method of treatment (prevention). Particularly offered is method of restenosis treatment or prevention inpatients suffering from diabetes. It is detected that local introduction of M-{5-[4-(4-methylpiperazinomethyl) benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidinamine or its pharmaceutically acceptable salt or crystal form under declared method provides unexpectedly high stability of compound within 45 days compared to its activity value when introduced as free form. ^ EFFECT: provides high stability of compound. ^ 5 cl, 7 ex
申请公布号 RU2341266(C2) 申请公布日期 2008.12.20
申请号 RU20040129281 申请日期 2003.02.27
申请人 NOVARTIS AG 发明人 PRESKOTT MARGARET FORNI;FELDMAN DEJVID LUIS
分类号 A61K31/501;C07D401/04;A61F2/00;A61F2/06;A61K31/496;A61K31/502;A61K31/506;A61K45/00;A61L29/16;A61L31/00;A61L31/16;A61P1/16;A61P3/10;A61P7/00;A61P7/02;A61P7/08;A61P9/00;A61P9/10;A61P9/14;A61P29/00;A61P35/00;A61P37/04;A61P41/00;A61P43/00 主分类号 A61K31/501
代理机构 代理人
主权项
地址